DrugPatentWatch Database Preview
Amneal Pharms Co Company Profile
What is the competitive landscape for AMNEAL PHARMS CO, and what generic and branded alternatives to AMNEAL PHARMS CO drugs are available?
AMNEAL PHARMS CO has sixty-one approved drugs.
There are two tentative approvals on AMNEAL PHARMS CO drugs.
Summary for Amneal Pharms Co
| US Patents: | 0 |
| Tradenames: | 58 |
| Ingredients: | 57 |
| NDAs: | 61 |
Drugs and US Patents for Amneal Pharms Co
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms Co | PARICALCITOL | paricalcitol | SOLUTION;INTRAVENOUS | 206699-003 | Mar 9, 2017 | AP | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Amneal Pharms Co | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 208850-003 | Oct 16, 2018 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Amneal Pharms Co | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | SOLUTION;INTRAVENOUS | 207548-001 | Sep 8, 2017 | AP | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for AMNEAL PHARMS CO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
| ➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
